Similarly, changes in exercise habitswhether increased weekend activity or reduced movement on certain daysdirectly affect insulin sensitivity and glucose utilisation
A clinic that reviews the research with you, sets a realistic timeline, and is willing to say a peptide is not worth it for your case is one that treats peptides for athletes as medicine, which is exactly the standard you want
Eli Lilly announced the topline results in December 2025: in obese participants with knee osteoarthritis, the 12 mg dose delivered a mean weight loss of 28,7% (32,3 kg / 71,2 lbs) at 68 weeks, and the 9 mg dose delivered a 26,4% reduction
The choice between these medications requires a thoughtful evaluation of individual needs, priorities, and treatment goals, underscoring the importance of personalized medicine in navigating the landscape of GLP-1 receptor agonists